Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays

Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II.

Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays

Serology testing for infectious diseases continues to be on the rise and newer instrument platforms are offering serology markers with improved sensitivity than previously available. In addition, there is continued progression with infectious disease screening protocols requiring serology testing for diagnosis, monitoring and treatment of infectious agents.

The Thermo Scientific MAS Omni Infectious positive and negative quality controls are  third-party, independent external controls used to assess the performance of serological assays for infectious diseases. Our new control set supports assays for HIV, Hepatitis C, Hepatitis B, HTLV and Syphilis. As with all Thermo Scientific MAS Quality Controls users can efficiently monitor assay performance, streamline operations and potentially reduce your spending without sacrificing quality or throughput.

We are expanding our quality control offering into a space which continues to increase each year as new pharma drugs are developed and enabling better identification and treatment for infectious diseases. Our team is committed to providing innovative solutions to support our customers productivity. The Thermo Scientific MAS Omni Infectious Controls are the first in a line of products we are continuing to develop to support the monitoring of  in vitro diagnostic tests."

Fernando Beils, Vice president and general manager, Thermo Fisher's niche diagnostics business

The Thermo Scientific MAS Omni Infectious Controls are available in the U.S. and Japan as IVD products and are intended for clinical use.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2020, July 03). Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20200703/Thermo-Scientific-MAS-Omni-Infectious-Controls-launched-to-assess-the-performance-of-serological-assays.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20200703/Thermo-Scientific-MAS-Omni-Infectious-Controls-launched-to-assess-the-performance-of-serological-assays.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays". News-Medical. https://www.news-medical.net/news/20200703/Thermo-Scientific-MAS-Omni-Infectious-Controls-launched-to-assess-the-performance-of-serological-assays.aspx. (accessed November 21, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2020. Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20200703/Thermo-Scientific-MAS-Omni-Infectious-Controls-launched-to-assess-the-performance-of-serological-assays.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Thermo Fisher Scientific collaborates with AstraZeneca and University of Nebraska Medical Center